Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study

Detalles Bibliográficos
Autores principales: Rayer, Cassandra, Nachury, Maria, Bourreille, Arnaud, Roblin, Xavier, Peyrin-Biroulet, Laurent, Viennot, Stephanie, Flamant, Mathurin, Laharie, David, Caron, Bénédicte, Dewitte, Marie, Siproudhis, Laurent, Fumery, Mathurin, Bouguen, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896746/
https://www.ncbi.nlm.nih.gov/pubmed/36732693
http://dx.doi.org/10.1186/s12876-022-02636-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896746/
https://www.ncbi.nlm.nih.gov/pubmed/36732693
http://dx.doi.org/10.1186/s12876-022-02636-9

Ejemplares similares